2. Academic Validation
  3. iASPP Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding

iASPP Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding

  • Cancer Cell. 2017 Nov 13;32(5):561-573.e6. doi: 10.1016/j.ccell.2017.09.008.
Wenjie Ge 1,  Kunming Zhao 1,  Xingwen Wang 1,  Huayi Li 1,  Miao Yu 2,  Mengmeng He 1,  Xuting Xue 1,  Yifu Zhu 1,  Cheng Zhang 3,  Yiwei Cheng 3,  Shijian Jiang 1,  Ying Hu 4
Affiliations

Affiliations

  • 1 School of Life Science and Technology, Harbin Institute of Technology, Harbin, Heilongjiang Province 150001, China.
  • 2 School of Chemistry, Harbin Institute of Technology, Harbin, Heilongjiang Province 150001, China.
  • 3 Department of Urology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province 150006, China.
  • 4 School of Life Science and Technology, Harbin Institute of Technology, Harbin, Heilongjiang Province 150001, China; Shenzhen Graduate School of Harbin Institute of Technology, Shenzhen 518055, China. Electronic address: huying@hit.edu.cn.
PMID: 29033244 DOI: 10.1016/j.ccell.2017.09.008
Abstract

Reactive Oxygen Species (ROS) have emerged as important signaling molecules that play crucial roles in carcinogenesis and cytotoxic responses. Nrf2 is the master regulator of ROS balance. Thus, uncovering mechanisms of Nrf2 regulation is important for the development of alternative treatment strategies for cancers. Here, we demonstrate that iASPP, a known p53 inhibitor, lowers ROS independently of p53. Mechanistically, iASPP competes with Nrf2 for Keap1 binding via a DLT motif, leading to decreased Nrf2 ubiquitination and increased Nrf2 accumulation, nuclear translocation, and antioxidative transactivation. This iASPP-Keap1-Nrf2 axis promotes Cancer growth and drug resistance both in vitro and in vivo. Thus, iASPP is an antioxidative factor and represents a promising target to improve Cancer treatment, regardless of p53 status.

Keywords

Keap1; Nrf2; ROS; cancer growth; chemoresistance; iASPP; renal cell carcinoma.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z